��������

Dr. Vinod Jaskula-Ranga is the Chief Executive Officer of Hunterian Medicine, a pre-clinical biotechnology company focused on CRISPR gene-editing technologies. He is the lead inventor on 4 U.S. and 3 international patents for his groundbreaking CRISPR and AAV therapeutic-delivery technology, and well over 50 U.S. and international patents pending. Dr. Jaskula-Ranga’s research has been highlighted by Chemical & Engineering News, Genetic Engineering & Biotechnology News, Biotechniques, Xconomy, and GenomeWeb, among others. Prior to founding Hunterian Medicine, he completed a fellowship in Genetic Engineering and Molecular Ophthalmology at the Wilmer Eye Institute of the Johns Hopkins University School of Medicine, where he received his Ph.D. in Molecular Biology and Genetics and trained in the laboratory of Nobel Laureate Dr. Carol Greider. Dr. Jaskula-Ranga also holds a B.A. in Religion from Case Western Reserve University, where he was awarded the Ratner Family Prize in recognition of the “Highest Academic Achievement.”